Search

Your search keyword '"Carter, B.D."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Carter, B.D." Remove constraint Author: "Carter, B.D." Database OAIster Remove constraint Database: OAIster
44 results on '"Carter, B.D."'

Search Results

1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

2. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

3. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

4. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

5. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

10. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

11. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

12. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).

13. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

14. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

16. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

17. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

18. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

19. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

20. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

21. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

22. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

23. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

24. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

25. Genome-wide association study of germline variants and breast cancer-specific mortality.

26. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

27. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

28. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

29. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

30. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

31. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

32. Genome-wide association study of germline variants and breast cancer-specific mortality.

33. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

34. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

35. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

36. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

37. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

38. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

39. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

40. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

41. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

42. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

43. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

44. The zinc finger protein NRIF interacts with the neurotrophin receptor p75(NTR) and participates in programmed cell death

Catalog

Books, media, physical & digital resources